Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Celebrate International Women’s Day with These Gifts for the SuperWomen at Work  Business
  • ShemarooMe brings the treasure of all new Gujarati content with a line up of originals, direct to OTT films and plays English
  • Sakshi Bhogal received the award for India’s Best Personality Transformation Coach for Men National
  • Morari Bapu unveils “Tribhuvana Sutras for the Tribhuvana” on Guru Purnima Lifestyle
  • Airavat and Fly Sirius unite Under New Brand: Transworld Jets Business
  • How To File Consumer Court Complaints In India Online In 2024 Lifestyle
  • On this World Environment Day, Viral Desai plants 4,000 trees under ‘Satyagraha against Pollution’ Business
  • From Udaipur to Bollywood: Aikarth Purohit’s Musical Mastery Shines in The Sabarmati Report Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Concept Medical joining hands with API Noida hosts “Meet the Masters” a Continuous Medical Education (CME) Program at Radisson Blu MBD, Noida on DCB treatment Health
  • VeCura ReSculpt Launched by Actress Alya Manasa & Praba Reddy, in Chennai, Redefining Science-Led Non-Surgical Body Sculpting in South India Health
  • M.S Dhoni Bats for Kauvery Hospital Against COVID-19 Health
  • The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern Health
  • Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences Health
  • Narayana One Health Partners with dacadoo to Launch the One Health Score Health

Recent Posts

  • Insurance for Bikes Used Daily in Indian Traffic: The Coverage Logic Behind High-Usage Two-Wheelers
  • Third-Party Bike Insurance and Own Damage: How Indian Riders Balance Legal Compliance With Full Protection
  • From Scroll To Screen: When A Viral Musical Decided Hollywood Wasn’t Optional
  • Fifteen Years Later, the Throne Still Isn’t Empty — It’s Just Haunted
  • Rikhav Securities Announces Promoter Group Open Offer for Up to 26% Stake

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Chandni Soni Renowned Producer is back with Bumpy Ride of a Gujarati family Entertainment
  • Award-winning Technical Startup disrupts the job market with AI-powered resumes Business
  • Foundations of Success: IIM Rohtak Marks 15 Years of Leadership and Innovation Education
  • Nikhil and Siddharth from NSCI Club win Double Crowns at the Racketlon National Championship Press Release
  • Finlaw Becomes The First Legal Consultancy Firm In India To Have Its Presence In Metaverse Business
  • Dipak Tewari’s Munda Gunda Is Our New Favorite Punjabi Track and Yours Too! Business
  • Within 5 years, Enigma, a Madhya Pradesh startup eyeing to become a Rs 15-crore EV brand Business
  • Voices of Change: Government Launches Creative ‘Badalta Bharat’ Campaign with Prizes for Citizens National

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme